Supplementary Figure 5 from Safety and Efficacy of Intratumoral MEDI1191, an IL12 mRNA Lipid Nanoparticle, plus Intravenous Durvalumab in Patients with Advanced Solid Tumors: A First-in-Human Study
Authors:
- Benedito A. CarneiroBenedito A. Carneiro
- Thomas MarronTMThomas Marron
- Dmitriy ZamarinDZDmitriy Zamarin
- Eduardo CastañónECEduardo Castañón
- Sandip Pravin PatelSPSandip Pravin Patel
- Vivek SubbiahVSVivek Subbiah
- Inderjit MehmiIMInderjit Mehmi
- Anthony El-KhoueiryAEAnthony El-Khoueiry
- Arjun OberoiAOArjun Oberoi
- Michael AbadierMAMichael Abadier
- Emily C. JenningsEJEmily C. Jennings
- Vincent DuboisVDVincent Dubois
Open Access
- 2 November 2026
- other
- Published by American Association for Cancer Research (AACR)